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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S291designer series describes ten year survival rates of up to 98%, with no
failures due to polyethylene wear or aseptic loosening of the tibial
component.
However, some smaller non-designer series have failed to replicate these
results. Recent commentaries on registry data have added to the debate
and there is still some confusion as to the true outcome of this procedure. It
has been suggested that both the centre and the individual surgeons
experience are critical is achieving good results. As yet no previous authors
have presented the results of trainees with this prosthesis. Traineesmay be
expected to achieve worse results with a technique that is highly surgeon
dependent.
The aim of this study is to present the survival of a large consecutive cohort
of medial OUKA performed in a specialist centre, bymultiple non-designer
surgeons, with the majority performed by trainees.
Methods: 1085 consecutive primary medial OUKA in 944 patients per-
formed between 1998 and 2008 were identiﬁed at a tertiary centre of
excellence from operative records. In each case the operation was per-
formed by a lower limb arthroplasty surgeon outside the designer team.
Operations performed by both trainee and consultant surgeons were
included. Failure was deﬁned as need for revision of any of the prosthetic
components for any cause and identiﬁed from hospital records, repeat
postal questionnaire to all patients and telephone follow-up of non-
responders. Family Doctor records were consulted in patients who
remained uncontactable. In patients who had died the Family Doctor was
contacted to determine the status of the knee at time of death. Survivor-
ship analysis was by construction of life table and cumulative survival
calculation. Results were stratiﬁed by grade of surgeon and level of
supervision.
Results: 1085 patients with an average age of 67yrs (SD 6.9) at time of
operation were identiﬁed. 681 (62.8%) knees were inserted by over 50
different trainees, 404 (37.2%) by 9 different consultants. At 10 years, 9
(0.83%) patients were lost to follow up and 76 (7%) had died. 46 knees
underwent revision surgery; 34 were revised to total knee arthroplasty
(TKA), 3 had revision of tibial or femoral component, 5 had additional
lateral unicompartmental knee arthroplasty for lateral compartment
progression of arthritis, and 4 underwent bearing change for dislocation or
impingement. The best case survival for the Oxford Medial Uni-
compartmental Knee Arthroplasty was 91% at 10 years. There was no
difference in the survival rates between consultants or registrars (p¼0.47).
If the Consultant was not in theatre at the time of the operation, registrars
achieved a 95% 10 year survival. The presence of the Consultant in theatre
with the trainee reduces survival to 82% at 10 years.
Conclusions: This is the largest single centre non designer series of Oxford
Unicompartmental Knee Arthroplasty ever reported and it demonstrates
excellent survival at 10 years. Over 60 surgeons were involved and there
was no difference in terms of survival between trainee and consultant
surgeons. These excellent results may include well established patient
selection criteria, thorough training programs and close expert supervision
of trainees who are not left to operate unsupervised until thoroughly
competent. Surprisingly, the presence of a consultant supervising a trainee
at the time of the operation led to a reduced 10 year survival. This may be
due to the fact that only fully trained competent registrars are left to
operate unsupervised and more junior and therefore less proﬁcient
trainees are those who are more closely supervised.
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OBESITY, VARUS ALIGNMENT AND MEDIAL COMPARTMENT KNEE OA
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Purpose: Varus alignment and obesity are both risk factors for the
progression of medial compartment knee OA and are the targets of various
interventions. The purpose of the present study was to evaluate the effect
of preoperative weight loss on knee-related outcome measures after
medial opening wedge high tibial osteotomy (HTO) for patients with
obesity, varus alignment and medial compartment knee OA. Wehypothesized that decreases in bodyweight preoperatively would result in
better knee-related outcomes 6 months postoperatively.
Methods: A total of 16 patients participated in this prospective cohort
study with matched historical controls. Eight patients completed an 8-
week physiotherapy program (2days/week), supplemented with fat loss
and body composition seminars (1day/week). These patients were
matched to historical controls based on sex, age (within 5 years), BMI
(within 2 points), Kellgren and Lawrence grade in the medial compart-
ment, and Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain
Domain (within 10 points). Outcome measures included the following: 3D
gait analysis (external knee adduction moment and gait speed), all KOOS
domains, the Lower Extremity Functional Scale (LEFS) and the Short Form
12 (SF-12) health status questionnaire. Changes from baseline to 6 months
after surgery were compared between groups using paired t-tests.
Results: The mean weight-loss before surgery was 4.7 kg (95%CI: 2.7, 6.8
kg) for the weight-loss group. Their mean weight-gain 6 months after
surgery was 1.5 kg (95%CI: -0.6, 3.6 kg). At 6 months after surgery, weight
in the preoperative weight-loss group was signiﬁcantly lower than the
controls [mean difference (95%CI): -2.5 kg (-5.4 , -0.3 kg)]. Both groups
improved substantially on all outcomes after surgery. However, there were
no signiﬁcant differences between groups. Between-group mean differ-
ences (95%CI) in change scores were as follows (weight-loss group minus
control group): Peak knee adduction moment, -1.9 Nm (-16.1, 13.8 Nm);
gait speed, 0.07 m/sec (-0.09, 0.22 m/sec); KOOS Pain domain, -2.1 (-21.3,
17.2); LEFS, -3.6 (-19.7, 12.4); SF-12 physical component summary, 1.5 (-7.8,
10.7); SF-12 mental component summary, 1.8 (-7.6, 11.3).
Conclusions: Although the extremes of the 95% conﬁdence intervals do
not exclude potentially clinically important differences between groups,
the present results suggest that obese patients with medial compartment
knee OA who lose weight before medial opening wedge HTO do not have
signiﬁcantly better knee-related outcomes 6 months postoperatively than
similar patients who do not lose weight preoperatively.
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NOVEL CORTICOSTEROID-CONTAINING VISCOSUPPLEMENT
FORMULATION PREVENTS POTENTIAL STEROID-INDUCED ADVERSE
EFFECTS ON CARTILAGE PROTEOGLYCANS
D. Gravett 1, H. Aberman 2, T. Simons 2, P. He 1, H. Panchal 1. 1Carbylan
BioSurgery, Inc, Palo Alto, CA, USA; 2Applied Biological Concepts, Inc, Los
Alamitos, CA, USA
Purpose: Viscosupplements and corticosteroids are commonly used intra-
articularly to treat the pain associated with osteoarthritis of the knee.
Viscosupplements are effective for up to six months but often have a slow
onset (4-6 weeks) for pain relief. Corticosteroids provide rapid pain relief
but often fail to provide long-term relief. A novel viscosupplement,
Hydros-TA, was developed to provide both rapid and long lasting pain
relief for the treatment of pain associated with osteoarthritis. The visco-
supplement comprises a low dose (10 mg) corticosteroid, triamcinolone
acetonide (TA), that is physically trapped within a crosslinked hyaluronic
acid based hydrogel bead suspended in a hyaluronic acid solution
(Hydros). The biocompatibility of this novel viscosupplement was studied
following intra-articular injection into the knee (Stiﬂe) of a goat to
demonstrate that this combination product did not cause adverse effects
on the cartilage and local joint tissue.
Methods: Thirty-six (36) adult goats, 18 castrated males and 18 females
were used to evaluate the local and systemic biocompatibility of the intra-
articular injections of 5.0 ml of Test or Control Material with 6 animals (3
males/3 females) per group. The following 6 treatment groups were used:
(1) Saline, (2) Hydros (viscosupplement with no corticosteroid), (3)
Hydros-TA(10mg), (4) Hydros-TA(40mg), (5) TA(10mg) and (6) TA(40mg).
The TA doses were scaled to animal weight and joint size. The contralateral
knee served as an internal control for each animal. The local biocompati-
bility was evaluated by gross, quantitative and histological analysis of the
joint and synovial ﬂuid at 28 days and 84 days post injection. The Mankin
Scoring system was used to access the effects of the treatment groups on
the joint cartilage. Systemic biocompatibility was evaluated by analysis of
blood chemistry and body weight pre-injection and at the time of sacriﬁce
as well as by histological analysis of the major organs.
